These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36808609)

  • 1. Propensity score-matched analysis of long-term outcomes for living kidney donation in alternative complement pathway diseases: a pilot study.
    Caliskan Y; Safak S; Oto OA; Velioglu A; Yelken B; Mirioglu S; Dirim AB; Yildiz A; Guller N; Yazici H; Ersoy A; Turkmen A; Lentine KL
    J Nephrol; 2023 May; 36(4):979-986. PubMed ID: 36808609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes of Living-Related Kidney Donation for Alport Syndrome Spectrum: A Propensity Score-Matched Analysis.
    Oto OA; Safak S; Mirioglu S; Yelken B; Velioglu A; Dirim AB; Guller N; Yildiz A; Ersoy A; Turkmen A; Yazici H; Lentine KL; Caliskan Y
    Am J Nephrol; 2022; 53(8-9):628-635. PubMed ID: 36349757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo thrombotic microangiopathy in two kidney transplant recipients from the same deceased donor: A case series.
    Roberts D; Siegman I; Andeen N; Woodland D; Deloughery T; Rueda J; Olyaei A; Rehman S; Norman D; Lockridge J
    Clin Transplant; 2020 Jul; 34(7):e13885. PubMed ID: 32314417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
    Vernon KA; Ruseva MM; Cook HT; Botto M; Malik TH; Pickering MC
    J Am Soc Nephrol; 2016 May; 27(5):1334-42. PubMed ID: 26374608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy].
    Yurova VA; Kozlovskaya NL; Bobrova LA; Kozlov LV; Andina SS; Demyanova KA
    Ter Arkh; 2023 Aug; 95(6):475-480. PubMed ID: 38158966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experience.
    Kant S; Bhalla A; Alasfar S; Alachkar N
    BMC Nephrol; 2020 May; 21(1):189. PubMed ID: 32434487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry.
    Halimi JM; Al-Dakkak I; Anokhina K; Ardissino G; Licht C; Lim WH; Massart A; Schaefer F; Walle JV; Rondeau E
    J Nephrol; 2023 Apr; 36(3):817-828. PubMed ID: 36152218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
    J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center experience of post-transplant atypical hemolytic uremic syndrome.
    Abu Jawdeh BG; Khan MA
    Clin Nephrol; 2023 Aug; 100(2):75-81. PubMed ID: 37288831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Factor I Variants in Complement-Mediated Renal Diseases.
    Zhang Y; Goodfellow RX; Ghiringhelli Borsa N; Dunlop HC; Presti SA; Meyer NC; Shao D; Roberts SM; Jones MB; Pitcher GR; Taylor AO; Nester CM; Smith RJH
    Front Immunol; 2022; 13():866330. PubMed ID: 35619721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
    Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
    Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-factor B antibodies in atypical hemolytic uremic syndrome.
    Khandelwal P; Nambiar S; Saini R; Saini S; Coshic P; Sinha A; Hari P; Palanichamy JK; Bagga A
    Pediatr Nephrol; 2024 Jun; 39(6):1909-1916. PubMed ID: 38252289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.
    Gaggl M; Aigner C; Csuka D; Szilágyi Á; Prohászka Z; Kain R; Haninger N; Knechtelsdorfer M; Sunder-Plassmann R; Sunder-Plassmann G; Schmidt A
    J Am Soc Nephrol; 2018 Mar; 29(3):1020-1029. PubMed ID: 29282226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
    Sethi S; Fervenza FC
    Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report.
    Bruno V; Barth D; Jauhal A
    Can J Kidney Health Dis; 2023; 10():20543581231209009. PubMed ID: 37942411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series.
    Ravindran A; Pereira Palma LM; Fervenza FC; Sethi S
    Kidney Int Rep; 2023 Mar; 8(3):619-627. PubMed ID: 36938079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
    Front Immunol; 2022; 13():909503. PubMed ID: 35720299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.